Edition:
United States

Taro Pharmaceutical Industries Ltd (TARO.N)

TARO.N on New York Stock Exchange

100.30USD
11:46am EST
Change (% chg)

$0.16 (+0.16%)
Prev Close
$100.14
Open
$101.34
Day's High
$102.68
Day's Low
$99.97
Volume
7,720
Avg. Vol
37,342
52-wk High
$128.25
52-wk Low
$93.59

Chart for

About

Taro Pharmaceutical Industries Ltd. (Taro) is a science-based pharmaceutical company. The Company operates principally through three entities: Taro Pharmaceutical Industries Ltd. (Taro Israel), and two of its subsidiaries, Taro Pharmaceuticals Inc. (Taro Canada) and Taro U.S.A. The Company markets over 200 pharmaceutical... (more)

Overall

Beta: 0.62
Market Cap(Mil.): $4,015.87
Shares Outstanding(Mil.): 40.10
Dividend: --
Yield (%): --

Financials

  Industry Sector
P/E (TTM): -- 30.98 16.31
EPS (TTM): -- -- --
ROI: -- 14.12 35.74
ROE: -- 15.72 17.71

BRIEF-Taro Pharmaceutical Industries Posts Q3 Earnings Per Share $0.45

* ‍EXCLUDING IMPACT OF ONE-TIME TAX RE-MEASUREMENT, EARNINGS PER SHARE FOR QUARTER WOULD BE $1.37​ Source text for Eikon: Further company coverage:

Feb 07 2018

BRIEF-Bellus Health Receives Milestone Payment From Taro Pharmaceuticals

* BELLUS HEALTH RECEIVES MILESTONE PAYMENT FROM TARO PHARMACEUTICALS Source text for Eikon: Further company coverage:

Jan 09 2018

BRIEF-Taro Pharmaceutical quarterly earnings per share $1.30

* Taro Pharmaceutical Industries Ltd-qtrly ‍shr $1.30​ Source text for Eikon: Further company coverage:

Nov 07 2017

BRIEF-Taro announces joining of CEO

* Taro Pharmaceutical Industries Ltd - ‍ Uday Baldota has joined company as its chief executive officer ("CEO") effective August 28, 2017​

Sep 01 2017

Earnings vs. Estimates